Trastuzumab is a monoclonal antibody specifically designed to target HER2 receptors on breast cancer cells. It flags the cancer cells for destruction by the body's immune system.
Nausea, Headache, Rash, Reduced blood platelets, Congestive cardiac failure, Insomnia (difficulty in sleeping), Infection, Upper respiratory tract infection, Nasopharyngitis, Fatigue, Fever, Anemia, Chills, Diarrhoea, Cough, Weight loss, Altered taste, Mucosal inflammation, Decreased white blood cell count (neutrophils), Stomatitis (Inflammation of the mouth)
Trastuzumab is used in the treatment of breast cancer.
Yes, Trastuzumab is a hazardous drug and is supposed to be administered under medical supervision only.
Q. Is Trastuzumab cytotoxic?Yes, Trastuzumab is cytotoxic